Biologic or biosimilar treatment success depends on your goals, but here’s some of what you should look for.

Biologic drugs have altered the course of rheumatoid arthritis for many people, but what happens if you try one and it doesn't work? WebMD explains.

Participants who started a biologic in the first month had more than five times greater odds of being in the rapid improvement group than in the slow improvement group (odds ratio [OR], 5.33; P ...

Among 11,992 adult patients newly initiating biologic therapy (median age, 47 years; 52.7% women), 1293 (10.8%) underwent a biologic switch during a minimum follow-up of 90 days.

Adjusting for a host of potential influences on recurrence risk -- including age, cancer type and original stage, and duration of remission -- still indicated no increased risk for cancer relapse ...

COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted ...

Biologic Dupilumab Shows Sustained Benefit in Asthma Patients — Reduced oral corticosteroid use, improved lung function maintained after nearly 2 years by Salynn Boyles, Contributing Writer ...

SAN FRANCISCO — Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, according to an abstract presented at the American ...

Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers ...